Hints and tips:
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...wants a pivot in the biotech’s sales strategy for its Covid-19 shot, which is based on traditional vaccine technology, to target older people unnerved by rare side effects associated with mRNA jabs from Pfizer...
...Additional reporting by Oliver Barnes in New York...
...“The hegemony of crewnecks has been going on for so long that the younger generations think the V-neck is a recent invention,” says menswear designer Oliver Spencer....
...“Our industry should take these findings very seriously,” said Oliver Bilal, head of Emea distribution at Invesco....
...The BioNTech/Pfizer vaccine was 95 per cent against the original virus strain....
...Two doses of the BioNTech/Pfizer vaccine provide 70 per cent protection against being admitted to hospital with the Omicron coronavirus variant, according to the first real-world analysis of protection against...
...However, Ugur Sahin, head of BioNTech, who developed the vaccine now produced by Pfizer, struck a more positive note....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...One senior Department of Health insider said: “We’ll be giving Pfizer to those who had AstraZeneca the first time, and AstraZeneca to those who had Pfizer....
...Additional reporting by Kiran Stacey in Washington, Oliver Barnes and Sarah Neville in London, Erika Solomon in Berlin, Nikou Asgari in New York, Mehul Srivastava in Jerusalem, and Sam Fleming in Brussels...
...According to Public Health England, both the Oxford/AstraZeneca and BioNTech/Pfizer vaccines are only 33 per cent effective against symptomatic disease after one dose, with efficacy rising steeply after...
...The company’s pipeline had been transformed since the Parisian saw off a takeover bid from Pfizer in 2014....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Brunswick Group hired former Pfizer China government affairs vice-president Xi Qing as a partner in Asia....
Technical solution to legal problem kept ride-sharing drivers on the road
...Oliver Meyer has joined the Baird Global Investment Banking’s European investment banking group as a managing director....
...Deutsche Bank has named Greg Sommer and Oliver Schiller as its new global co-heads of natural resources. Both men will join the bank in early September....
...Pfizer would have recouped its losses within two months....
International Edition